The role of pomalidomide in treatment of relapse and refractory multiple myeloma

The role of pomalidomide in treatment of relapse and refractory multiple myeloma

Background. Over the past 15 years, the therapeutic breakthrough in the treatment of multiple myeloma observed primarily due to the emergence of new drugs. Since the characteristic of the disease is a chronic course with consecutive periods of remissions and relapses, the search for new effective tr...

Full description

Saved in:
Bibliographic Details
Main Authors: S. V. Voloshin, S. Yu. Linnikov, A. D. Garifullin, A. A. Kuzyaeva, A. V. Shmidt, A. Yu. Kuvshinov, A. N. Bogdanov, M. A. Mikhileva, I. S. Martynkevich, M. N. Zenina, S. V. Sidorkevich
Format: Article
Language:Russian
Published: ABV-press 2022-01-01
Series:Онкогематология
Subjects:
multiple myeloma
pomalidomide
autologous hematopoietic stem cell transplantation
neutropenia
hematological toxicity
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/517
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://oncohematology.abvpress.ru/ongm/article/view/517

Similar Items